レコードの引用形

APA(7版)引用形式
Hsu, A., Huntington, K. E., Souza, A. D., Zhou, L., Olszewski, A. J., Makwana, N. P., . . . Carneiro, B. A. (2022). Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma. Taylor & Francis Group.
Chicagoスタイル(17版)引用形式
Hsu, Andrew, et al. Clinical Activity of 9-ING-41, a Small Molecule Selective Glycogen Synthase Kinase-3 Beta (GSK-3β) Inhibitor, in Refractory Adult T-Cell Leukemia/lymphoma. Taylor & Francis Group, 2022.
MLA(9版)引用形式
Hsu, Andrew, et al. Clinical Activity of 9-ING-41, a Small Molecule Selective Glycogen Synthase Kinase-3 Beta (GSK-3β) Inhibitor, in Refractory Adult T-Cell Leukemia/lymphoma. Taylor & Francis Group, 2022.
警告: この引用は必ずしも正確ではありません.